top of page
PCSK-9 inhibitors: NICE guidance & eligibility criteria
Wed, 16 Dec
|Virtual Medical Educators Facebook Page
Registration is Closed
See other eventsTime & Location
16 Dec 2020, 19:00 – 20:00 GMT
Virtual Medical Educators Facebook Page
Guests
About the Event
PCSK-9 inhibitors is a game changer in the management hypercholestrolaemia refractory to treatment with other options and to patients with Statins intolerance. However, they are a very expensive class of drugs and one needs to follow very strict criteria. Hana Beba our senior pharmacist will explain how they work and the eligibility criteria according to NICE guidelines.
bottom of page